Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-16 4:18 pm Purchase | 2026-09-30 | 13G | ADARX PHARMACEUTICALS INC ADRX | LAV Biosciences Fund V, L.P. | 11,858,655 11.100% | 11,858,655 (New Position) | Filing History |
| 2026-10-05 5:35 pm Purchase | 2026-09-28 | 13D | ADARX PHARMACEUTICALS INC ADRX | SR One Capital Management, LLC | 9,936,661 9.300% | 9,936,661 (New Position) | Filing History |
| 2026-10-02 5:36 pm Purchase | 2026-09-28 | 13D | ADARX PHARMACEUTICALS INC ADRX | ORBIMED ADVISORS LLC | 14,913,764 14.000% | 14,913,764 (New Position) | Filing History |
| 2026-10-01 4:00 pm Purchase | 2026-09-24 | 13G | ADARX PHARMACEUTICALS INC ADRX | BCLS Fund III Investments, LP | 6,728,970 6.300% | 6,728,970 (New Position) | Filing History |